ABBOTT INDIA LTD
MUMBAI, Aug. 20, 2020 — New global market research, released today from Abbott, takes a deep dive into the barriers of cardiovascular patient care and shows that more than 80% of physicians and hospital administrators view technology and data as critical to addressing challenges before, during and after treatment. According to the new data, 79% of patients have confidence in physicians' decision-making, but they feel technology can help deliver more personalized care. More than half of vascular patients globally believe that utilizing the latest diagnostic and treatment technologies can help physicians determine the best treatment plan.
The findings from Beyond Intervention, a report commissioned by Abbott, show that using advanced technologies can enable more precise diagnoses and better treatment strategies to ensure the best possible results. The Survey was designed to examine the current state of vascular care and how health care leaders, physicians and patients view the importance of incorporating data and technology into treatment pathways.
"Technological advances can help providers select and treat the right patients, at the right time, with the right approach, thereby easing the burden on patients, healthcare workers and healthcare systems," said Nick West M.D., chief medical officer and divisional vice president of Medical Affairs at Abbott’s vascular business. "This research identifies how physicians and administrators can improve patient care—and the need for the right use of technology and data to enable more precise diagnoses, informed decisions and determine better treatment strategies to ensure the best possible patient health."
Innovating New Solutions Based on Clinical Need
Cardiovascular disease (CVD) remains the leading cause of death worldwide, but with proper interventions and post-procedural care, up to 80% of CVD-related deaths may be preventable . In India, CVD is the leading cause of mortality . According to the Global Burden of Disease study, the estimate of age-standardized CVD death rate of 272 per 100,000 population in India is higher than the global average of 235 per 100,000 population . To better understand growing treatment gaps in cardiovascular health care and identify new ways to continue addressing existing challenges, Abbott commissioned the Beyond Intervention survey to capture feedback from more than 1,400 physicians, health system administrators and patients to uncover their views on how data and technology could better guide physician decision making and improve patient outcomes.
Abbott has targeted gaps in vascular health care through technology development and deployment. By focusing on innovative approaches to patient management, including the deployment of new technology smart applications, remote monitoring and minimally invasive approaches, the company is improving patient care and working to address many of the issues identified by respondents to the Beyond Intervention survey.
In addition, the implementation of new visualization tools like Optical Coherence Tomography (OCT) imaging into percutaneous coronary intervention (PCI) workflows has driven better treatment decisions and ultimately led to improved patient outcomes. As a result, the company has helped enhance cardiovascular care and deliver maximum value to physicians, hospitals and patients alike by utilizing technology to improve patient care before initial treatment, during the procedure and during the post-treatment follow up.
Speaking on the value of technology, “Dr. Ashok Seth, President, Asia Pacific Society of Interventional Cardiology and Chairman, Fortis Escorts Heart Institute and Governance Board says, “Clearly advances in medical technology, especially in the last 20 years, research leading to evidence-based action plans and appropriate timing & choice of medical procedure, have helped in ensuring best outcomes for my patients in the long-term. I feel fortunate to be a part of that experience and to deliver the best results for patients. I believe the most important service I can do to my patients is not just to get them better, but importantly that they should remain well enough to not need any further interventions for the longest period of time. Advances in technology help me achieve this.”
Key Research Findings (India)
The Beyond Intervention research uncovered key views from physicians, hospital administrators and patients that showcase the demand for improved communication between physicians, hospital administrators and patients. Key findings from the research for India include:
Maneesh Juneja, Digital Health Futurist, UK says, "India is a diverse country which faces many challenges in vascular care. However, if we find a way to include different voices in the design and implementation of emerging technologies, we have the ability to overcome many of these challenges. Fostering a culture of greater collaboration within India is critical to ensure that many more people can continue to benefit from technological innovations in vascular care. Innovation needs people, process and policy to move in tandem."宇多田美香bt种子下载宇多田美香bt种子下载,小辣椒苹果版app下载小辣椒苹果版app下载,夫君个个太妖孽 免费阅读夫君个个太妖孽 免费阅读
About Beyond Intervention Research
Abbott surveyed 1,432 physicians, health system administrators and patients from December 2019 through January 2020 to understand the effect of advancements in cardiovascular technology on patient care. Respondents to the online survey represent nine countries: The United States, United Kingdom, China, Japan, France, Germany, India, Italy and Brazil. The Beyond Intervention market research uncovers the improved patient outcomes that can be achieved through technological innovation and improved data insights across a patient’s care journey. Data-driven decision making and collaboration between physicians, administrators and patients will improve overall patient treatment plans – from understanding risk factors and comorbidities to providing precise diagnoses to making the right treatment decisions that greatly improve wellness and quality of life.
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 107,000 colleagues serve people in more than 160 countries. In India, Abbott was established in 1910, and is one of the country's oldest and most admired healthcare companies. With over 12,000 employees in the country, Abbott in India is helping to meet the healthcare needs of consumers, patients and doctors throughout urban and rural India.
Connect with us at and , on Facebook at www.facebook.com/Abbott and www.facebook.com/AbbottIndia, and on Twitter @AbbottNews and @AbbottGlobal.
Connect with us at www.abbott.com, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews and @AbbottGlobal.
Nandini Goswami, firstname.lastname@example.org
Mandira Viegas, email@example.com
3 Srinath Reddy K, Shah B, Varghese C, Ramadoss A. Responding to the threat of chronic diseases in India. Lancet. 2005; 366:1744–1749. doi: 10.1016/S0140-6736(05)67343-6.
4 Prabhkaran, D. , Jeemon, P. Roy, A. : Cardiovascular Diseases in India Current Epidemiology and Future Directions 2016;133:1605–1620. DOI: 10.1161/CIRCULATIONAHA.114.008729
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.